NCT01594216 · Interventional trial
Ruxolitinib in Estrogen Receptor Positive Breast Cancer
Overall registry status Completed
Phase 2
Conditions Estrogen-receptor Positive Invasive Metastatic Breast Cancer
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory